Pulmonary Hypertension Medications
After a positive diagnosis of PH, doctors will focus on creating a management program, usually featuring one or more medications for Pulmonary Hypertension. Treatment often proceeds in stages, depending upon the patient's response to each of the possible medications for Pulmonary Hypertension. The initial phase focuses on identifying the degree to which the pulmonary arteries can be dilated using medications for Pulmonary Hypertension. The patient will be given known vasodilators such as inhalable nitric oxide or intravenous prostacyclin or adenosine.
Patients who experience a notable drop in pulmonary vascular resistance are given medications for Pulmonary Hypertension designed to control pulmonary pressure, such as oral calcium channel blockers and anticoagulants. If the fall in pressure is minimal, patients will be given these same medications for Pulmonary Hypertension, but in higher doses coupled with vasodilators. These patients may also be candidates for heart and lung transplants.
Medications for Pulmonary Hypertension that are classified as vasodilators include Flolan, Remodulin and Tracleer. Two of these medications for Pulmonary Hypertension—Flolan and Remodulin—are injected (Flolan is administered intravenously, Remodulin subcutaneously). Both of these medications for Pulmonary Hypertension require that the patient wear a pack of some kind that releases the drug into the patient's system according to a timer. The third of these medications for Pulmonary Hypertension, Tracleer, is available in tablet form to be taken orally.
The newest medications for Pulmonary Hypertension are extremely expensive, and focus on treating symptoms, rather than reversing the damaged blood vessels. Medications for Pulmonary Hypertension often carry a high risk of side effects, such as the risk of sepsis associated with the use of Flolan, or birth defects resulting from Tracleer. While improvements can be made in the medications for Pulmonary Hypertension, many patients are still relying on the chance for a lung transplant as their best hope for treatment.
Medications for Pulmonary Hypertension may extend the lifespan of a patient for a few years, but there is as yet no cure for Pulmonary Hypertension. If you or a loved one is taking medications for Pulmonary Hypertension due to the use of diet drugs such as Fen Phen, consult an attorney to learn more about your legal rights. Medications for Pulmonary Hypertension are extremely expensive, and the costs may be the responsibility of a diet drug manufacturer. In addition to the cost of medications for Pulmonary Hypertension, drug manufacturers may be made to compensate for lost wages, pain and suffering, reduced quality of life, and more.
In societies where thinness is valued, it follows that there will be a constant struggle for people to lose weight. Since the dawn of modern medicine, that struggle has been met with countless drugs designed to make losing weight easy... read more
Canadians with pulmonary hypertension are struggling with the complications of the disease, according to results from a Canadian study, released yesterday from the Pulmonary Hypertension Association (PHA) of Canada's Patient and Caregiver Survey.
Study authors based their findings on a... read more
According to a new study from the University of Pennsylvania, women who undergo lung transplants are more likely than men to experience a certain type of injury afterwards.
The senior researcher of the study,... read more